Gene panel testing of 5589 <i><scp>BRCA</scp>1/2</i>‐negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer

Jan Hauke, Judit Horváth, Eva Groß, +42

Cancer Medicine

BRIP1 loss-of-function mutations confer high risk for familial ovarian cancer, but not familial breast cancer

Nana Weber‐Lassalle, Jan Hauke, Juliane Ramser, +34

Breast Cancer Research

Lactate regulates myogenesis in C2C12 myoblasts in vitro

Lena Willkomm, Sarah Schubert, Raphael Jung, +5

Stem Cell Research

Muscle FunctionSkeletal Muscle TissueCell CultureCellular PhysiologyOxidative Stress +15

Germline loss-of-function variants in the BARD1 gene are associated with early-onset familial breast cancer but not ovarian cancer

Nana Weber‐Lassalle, Julika Borde, Konstantin Weber‐Lassalle, +26

Breast Cancer Research

Association of Genomic Domains in <i>BRCA1</i> and <i>BRCA2</i> with Prostate Cancer Risk and Aggressiveness

Vivek Patel, Evan L. Busch, Tara M. Friebel, +258

Cancer Research

Deleterious somatic variants in 473 consecutive individuals with ovarian cancer: results of the observational AGO-TR1 study (NCT02222883)

Jan Hauke, Eric Hahnen, Stephanie Schneider, +31

Journal of Medical Genetics

Performance of Breast Cancer Polygenic Risk Scores in 760 Female<i>CHEK2</i>Germline Mutation Carriers

Julika Borde, Corinna Ernst, Barbara Wappenschmidt, +28

JNCI Journal of the National Cancer Institute

Clonal Hematopoiesis–Associated Gene Mutations in a Clinical Cohort of 448 Patients With Ovarian Cancer

Konstantin Weber‐Lassalle, Corinna Ernst, Kathrin Möllenhoff, +18

JNCI Journal of the National Cancer Institute

Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer

Muriel Rolfes, Julika Borde, Kathrin Möllenhoff, +23

Cancers

Breast OncologyGeneticsGenetic EpidemiologyGynecologyPathology +14

Diagnosis of Li-Fraumeni Syndrome: Differentiating <i>TP53</i> germline mutations from clonal hematopoiesis

Konstantin Weber‐Lassalle, Philipp Harter, Jan Hauke, +13

Human Mutation

GeneticsPathologyGynecologyTumor BiologyOvarian Cancer +15